Cyclerion Therapeutics, Inc. (KRSA) vs Syndax Pharmaceuticals, Inc. (SNDX)
Cyclerion Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Cyclerion Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($1.7B and $1.6B). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 222.3% against 30.8%. Cyclerion Therapeutics, Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (−115.4% vs −247.9%). Across the 18 metrics below, Syndax Pharmaceuticals, Inc. leads on 10 and Cyclerion Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | KRSA | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.78% | 65.16% |
| Operating margin | 0.00% | (77.05%) | 0.00% |
| Net margin | 0.00% | (87.60%) | 0.00% |
| Free cash flow margin | 0.00% | (87.64%) | 0.00% |
| Return on equity | (98.22%) | (255.93%) | (57.72%) |
| Return on assets | (82.29%) | (33.97%) | (49.22%) |
| Return on invested capital | (115.40%) | (247.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack